MOH — authorised 25 March 2003
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
MOH authorised Trovert on 25 March 2003
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 25 March 2003.
PHARMACIA AND UPJOHN holds the UAE marketing authorisation.